These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

422 related items for PubMed ID: 6810246

  • 1. Third-generation cephalosporins: comparative antibacterial activity against routine clinical isolates.
    Corser CA, Day GJ, Humble MW.
    N Z Med J; 1982 Jun 23; 95(710):414-6. PubMed ID: 6810246
    [Abstract] [Full Text] [Related]

  • 2. Comparative in vitro activities of third-generation cephalosporins.
    Fass RJ.
    Arch Intern Med; 1983 Sep 23; 143(9):1743-5. PubMed ID: 6615095
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Computerized analysis of activity profiles of beta-lactams].
    Pitton JS, Philippin JL, Fournier P.
    Pathol Biol (Paris); 1985 Jun 23; 33(5 Pt 2):581-5. PubMed ID: 3937131
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparison of cefoperazone, cefotaxime, and moxalactam (LY127935) against aerobic gram-negative bacilli.
    Lang SD, Edwards DJ, Durack DT.
    Antimicrob Agents Chemother; 1980 Mar 23; 17(3):488-93. PubMed ID: 6252831
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [In vitro activity of cefatiolene (RP 42,980) against hospital bacteria. Comparison with cefotaxime and lamoxactam. Results of a multicenter study].
    Duval J, Soussy CJ, Deforges L, Le Van Thoi J, Acar JF, Kitzis D, Dabernat H, Christol D, Bure A, Courtieu AL.
    Pathol Biol (Paris); 1983 May 23; 31(5):357-61. PubMed ID: 6312397
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A comparative study of the in-vitro activity of cefepime and other cephalosporins.
    Lim VK, Halijah MY.
    Malays J Pathol; 1993 Jun 23; 15(1):65-8. PubMed ID: 8277793
    [Abstract] [Full Text] [Related]

  • 18. Activities of cefoperazone, cefotaxime, cefuroxime, and cephalothin against 128 clinical isolates.
    Garcia-Rodriguez JA.
    Clin Ther; 1980 Jun 23; 3(Spec Issue):117-22. PubMed ID: 6248220
    [No Abstract] [Full Text] [Related]

  • 19. Dynamics of resistance to cephalosporins.
    Atkinson BA.
    Chemioterapia; 1985 Feb 23; 4(1):19-23. PubMed ID: 3986942
    [Abstract] [Full Text] [Related]

  • 20. In vitro antimicrobial activity of a novel aminothiazolylglycylcephalosporin, MT0703S, compared with that of ceftazidime, cefoperazone and aztreonam.
    Okamoto R, Hara T, Yoshida T, Orikasa Y, Ogino H, Iwamatsu K, Inouye S.
    Drugs Exp Clin Res; 1990 Feb 23; 16(4):157-65. PubMed ID: 2127567
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.